Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies

References

Page 1

	Year	Citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) E. Eisenhauer, P. Therasse, Jan Bogaerts, European Journal of Cancer Surgical OncologyRecist GuidelineMedicineCancer ManagementSolid Tumours	2008	28.6K
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, New England Journal of Medicine	2012	12.5K
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma James Larkin, Vanna Chiarion‐Sileni, René González, New England Journal of Medicine	2015	8K
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer Edward B. Garon, Naiyer A. Rizvi, Rina Hui, New England Journal of Medicine	2015	6.1K
Pembrolizumab versus Ipilimumab in Advanced Melanoma Caroline Robert, Jacob Schachter, Georgina V. Long, New England Journal of Medicine	2015	5.7K
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, The Lancet Oncology Checkmate 037MedicineMelanomaNivolumab Versus ChemotherapyImmune Checkpoint Inhibitor	2015	2.6K
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma Jeffrey S. Weber, F. Stephen Hodi, Jedd D. Wolchok, Journal of Clinical Oncology Surgical OncologyImmunologyPharmacotherapyMetronomic ChemotherapyDermatology	2017	1.1K
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab Camille Hua, Lise Boussemart, Christine Mateus, JAMA Dermatology	2015	638
Challenges of Guarantee-Time Bias Anita Giobbie‐Hurder, Richard D. Gelber, Meredith M. Regan Journal of Clinical Oncology EngineeringPrognosisVerificationProspective Cohort StudyLongevity	2013	430
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab Laura C. Cappelli, Anna Kristina Gutierrez, Alan N. Baer, Annals of the Rheumatic Diseases	2016	384

Page 1